Study of MAP0010 in Asthmatic Children and Adolescents

NCT00697801 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: MAP0010 low dose
DRUG: MAP0010 high dose
DRUG: Placebo

Sponsor

Allergan

Collaborators

[object Object]